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ABSTRACT
The ribonuclease A (RNase A) superfamily has been
thesubjectofextensivestudiesintheareasofprotein
evolution, structure and biochemistry and are excit-
ing molecules in that they appear to be responding to
unique selection pressures, generating proteins cap-
able of multiple and diverse activities. The RNase 4
and RNase 5/ang 1 shared locus breaks a pattern that
is otherwise canonical among the members of the
RNase A gene superfamily. Conserved among
humans, mice and rats, the locus includes two non-
coding exons followed by two distinct exons encod-
ing RNase 4 and RNase 5/ang 1. Transcription from
this locus is controlled by differential splicing and
tissue-specific expression from promoters located
50 to each of the non-coding exons. Promoter 1, 50
to exon I, is universally active, while Promoter 2, 50
to exon II, is active only in hepatic cells in promoter
assays in vitro. Transcription from Promoter 2 is
dependent on an intact HNF-1 consensus binding
site which binds the transcription factor HNF-1a.I n
summary, RNase 4 and RNase 5/ang 1 are unique
among the RNase A ribonuclease genes in that they
maintain a complex gene locus that is conserved
across species with transcription initiated from
tissue-specific dual promoters followed by differen-
tial exon splicing.
INTRODUCTION
The ribonuclease A (RNase A) superfamily has been the sub-
ject of extensive studies in the areas of protein evolution,
structure and biochemistry. RNase A (bovine pancreatic ribo-
nuclease), the prototype of this gene superfamily, was one of
the ﬁrst proteins to have its crystal structure solved and to be
chemically synthesized de novo (1,2). The molecular evolu-
tion of the RNase A vertebrate-speciﬁc enzyme family is
startlingly complex, as the various gene lineages (13 in
humans and, 9 in mice and rats) appear to be responding to
unique selection pressures, generating proteins capable of
reducing the infectivity of viruses, killing systemic pathogens
and inducing the growth of blood vessels while maintaining
conserved signature motifs (3–7). Until recently, the signature
motifs of this family included 6–8 cysteines which form the
disulﬁde bonds necessary to achieve the required 3D structure
and a catalytic triad composed of two histidines and a lysine
within a CKXXNTF motif. With the discovery of RNases -9,
-10, -11, -12 and -13 (3,8,9), these requirements have been
somewhat relaxed as these genes are clearly the derivatives of
the RNase A lineage based on sequence similarity and the
presence of the characteristic disulﬁde bridges, but they
lack the active site signature motif and, as such, are unlikely
to have ribonucleolytic activity.
With the elucidation of the human genome, Lander et al.
(10) noted the unique nature of the RNase A ribonucleases as
the only gene family with enzymatic activity clearly limited to
vertebrate species. The genes encoding RNase A ribonuc-
leases cluster on human chromosome 14; all with a presumed
simple genomic structure consisting of a small non-coding
exon I followed by an uninterrupted coding sequence on
exon II (11–14). Of Interest, the transcripts encoding each
of these ribonucleases are initiated from single promoters
located 50 to the non-coding exons and rely on the presence
of enhancers in the introns to achieve maximum levels of
transcription.
Notwithstanding the rich research history of the RNase A
superfamily, relatively little is known speciﬁcally about the
RNase 4 lineage. Human RNase 4 was ﬁrst described by
Shapiro et al. (15) after isolating the protein from conditioned
medium from an adenocarcinoma cell line. Two groups isol-
ated the cDNA encoding human RNase 4 (16,17). Rosenberg
and Dyer (17) found human RNase 4 to be a single copy gene
expressed in all tissues examined by northern analysis with the
exception of brain and placenta, with the highest expression
found in liver.
Conversely, more is known about the RNase 5/angiogenin
lineage. The angiogenins are structurally distinct from other
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haveonlysixofthe eightstandardcysteines. Angiogenin(ang)
was originally identiﬁed as a factor stimulating blood vessel
growth [reviewed in (5)]. Recently, mouse angiogenin (ang) 1
and ang 4, and human angiogenin have been identiﬁed as
microbicidal agents (6). Evolutionary analysis of the
angiogenin lineage from non-mammalian species suggests
that this group may be the most ancient form of the super-
family (3,5). While examining the expressed sequence tag
(EST) database, Strydom (5) noted that both human angio-
genin and mouse angiogenin 1 (ang 1) shared 50-untranslated
regions (5-UTRs) with RNase 4 and suggested that these genes
might exist in close proximity along the chromosome and that
the different mRNAs could be the products of differential
splicing. Alternatively, but less likely, the shared 50-UTRs
could have resulted from very recent duplications of the
non-coding exons, as duplication events are certainly very
prominent in the evolutionary history of the RNase A gene
family (18,19). In this work, we characterize RNase 4 and
RNase 5/ang 1 genes demonstrating that the two genes
share a common locus consisting of four exons and three
intervening introns in the mouse, rat and human genome.
We further demonstrate that transcription from the RNase
4–RNase 5/ang 1 locus is controlled by two promoters that
operate in a tissue-speciﬁc manner and that the proximal
promoter is absolutely dependent on an intact HNF-1a con-
sensus binding site.
MATERIALS AND METHODS
Cell culture
The following cell lines were purchased from American Type
Culture Collection (ATCC, Manassas, VA) and were main-
tained in RPMI 1640 supplemented with 10% fetal bovine
serum, L-glutamine and penicillin/streptomycin at 37 C
with 5% CO2 in a humidiﬁed incubator: MMSV (CCL-
163.2) and K-Balb (CCL-163.3) which are derivatives of
the mouse 3T3 ﬁbroblast cell line; RAW264.7 (TIB-71), a
mouse macrophage cell line; Hepa 1-6 (CRL-1830), a
mouse hepatoma cell line; Hep-G2 (HB-8065), a human
liver cell line and H-4-II-E (CRL-1548), a rat hepatoma
cell line.
Rapid amplification of cDNA ends (50 and 30 RACE)
Complementary DNA was synthesized from 1 mg RNA from
mouse liver, kidney and bone marrow with MMLV reverse
transcriptase as per the manufacturer’s instructions (SMART
RACE cDNA Ampliﬁcation kit, Clontech, Palo Alto, CA) and
then ampliﬁed using mouse RNase 4 speciﬁc oligonucleotides.
Sequences used are as follows:
50 RACE, 50-CTGAGGGTCCACATGCTGTCGAAG-30
30 RACE, 50-ATGATGCAGAGACGGAAGATGACT-30
The PCR conditions were as follows: 5 cycles of 94 C for 5 s
followed by 72 C for 3 min; then 5 cycles of 94 C for 5 s
followed by 70 C for 10 s followed by 72 C for 3 min; and
ﬁnally 25 cycles of 94 C for 5 s followed by 68 C for 10 s
followed by 72 C for 3 min. The cDNAs were gel puriﬁed
(BIO 101, Alta Vista, CA) and subcloned into the pCR2.1
(Invitrogen, San Diego, CA); multiple colonies were
sequenced in both directions. The sequences were assembled
using Sequencher 4.1 (GeneCodes, Ann Arbor, MI) to obtain
the full-length cDNA sequence. The GenBank accession num-
ber for the full length liver transcript is AY762362. The RNase
4 and RNase 5/ang 1 locus maps to mouse chromosome 14
(NT_039599, nt 6429305–6445565).
To determine the precise transcriptional start site(s) of the
human and rat RNase 4 gene, 50 RACE was performed using
liver and kidney mRNA as described above. Sequences of the
primers are as follows:
Human 50 RACE, 50-GAATCGCTGGTACATGCCATC-
CTGGCCATA-30 (GenBank accession no. U36775 (17),
nt 1–24).
Rat 50 RACE, 50-TCAGGGTCCACATGCTGTCTAAG-
GAAC-30 (GenBank accession no. AF041066 (20), nt
181–207).
Generation of the pGL3 enhancer reporter constructs
Fragments 500 bp 50 of exon 1 and exon II were generated by
PCR from genomic DNA and ligated into the BglII and
HindIII sites of the pGL3 Basic reporter vector (Promega,
Madison, WI). The resulting constructs are named according
to the gene segment contained: pGL3 Basic has no promoter,
pGL3-Pr1 contains the promoter region of 50 to exon I and
pGL3-Pr2 contains the promoter region 50 to exon II.
The following primers were used to generate the indicated
fragments:
50 Pr1 50-ctctctcctc AGATCT TCGTTGGTCTAGGGGT-
ATGATTCTCGCTTT-30
30 Pr1 50-ctcctcctc AAGCTT TGGGTGAGGTCGGCG-
TTGCCTGGCCACGCA-30
50 Pr2 50-ctctctcctc AGATCT TGAGTAGCCATAAATA-
TATATTCTATTTTC-30
30 Pr2 50-ctcctcctc AAGCTT CTAGAGGCTCCTCA-
CAGGCTGGTAATATACA-30
The underlined nucleotides encode the BglII restriction
enzyme site on the 50 primer and HindIII on the 30 primers
and the lower case letters indicate a sequence added to aid in
the restriction digestion of the PCR generated fragments. All
constructs were conﬁrmed by automated sequencing using the
dRhodamine sequencing kit (Applied Biosystems, Foster City,
CA) on the ABI377 Automated Sequencer followed by ana-
lysis using Sequencher 3.1.1 software (Gene Codes Corpora-
tion, Ann Arbor, MI).
Identification of potential transcription factor
binding sites
Analysis of the potential transcription binding sites was done
using Transcriptionelementsearchsystem (TESS) available at
http://www.cbil.upenn.edu/tess.
Mutagenesis of the HNF-1 transcription factor binding
site in the mouse RNase 4 Pr2 construct
The putative transcription factor binding site HNF-1,
identiﬁed within the sequence of Pr2 (deﬁned above), was
mutated from GTTAATATTTGAC to ATGAAGATTTGAC
(underlined residues highlight mutations) by site directed
mutagenesis (QuickChange Kit, Stratagene, La Jolla, CA)
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mutation(pGL3 Pr2mHNF-1) was conﬁrmed by DNAsequen-
cing and the effect of the mutation was assessed in the dual
luciferase assay as described below. The residues selected for
mutation were those shown by Ryffel et al. (21) to be neces-
sary for the liver-speciﬁc transcription.
Transient expression and the promoter reporter assay
Thecelllines were plated at300000cells perwell inasix-well
plate 24 h prior to transfection. About 5–10 ml of lipofectin
(Life Technologies, Rockville, MD) was added according to
the manufacturer’s recommendation to transfect 0.5 mg of the
pGL3-derived constructs (pGL3 Basic, vector only; pGL3 Pr1,
Pr1; pGL3 Pr2, Pr2; and pGL3 Pr2mHNF-11) and 0.1 mg pRL
CMV reporter plasmid into the cell line. The dual luciferase
assay (Promega, Madison, WI) was used to determine tran-
scriptional activity of the reporter constructs according to
manufacturer’s suggestions. The ﬁreﬂy luciferase (experi-
mental promoter construct) activities of each of the experi-
mental constructs were normalized to the Renilla luciferase
(co-transfectant control promoter construct) activity. All
experiments were performed in triplicate and statistical signi-
ﬁcance was determined using the two-tailed t-test assuming
unequal variance (Microsoft Excel). All data are reported as
mean – standard error of the mean (SEM).
Biotin labeling of 30-OH ends of EMSA probes
Five picomoles of 30-OH ends of oligonucleotides were end-
labeled with biotin using terminal deoxynucleotidyl trans-
ferase (TdT, Pierce, Rockford, IL). Brieﬂy, 5 pmol of the
complementary oligonucleotides was labeled separately in
37 C incubation, with 1· TdT reaction buffer, 0.5 mM
Biotin-N4-CTP and 10 U TdT in a 50 ml reaction. After
30 min, 2.5 ml of 0.2 M EDTA was added to terminate the
reaction. Thebiotin-labeled oligonucleotideswere extracted in
the aqueous phase of CHCl3:isoamyl alcohol (24:1). A double
stranded electromobility shift assay (EMSA) probe was made
by annealing a 1:1 mix of the biotin-labeled complementary
oligonucleotides by heating to 65 C for 10 min followed by
slowly cooling to room temperature. The biotin-labeled
EMSA probe was stored at  20 C until needed. Unlabeled
Self and mutated Self (mSelf) complementary oligonuc-
leotides were also annealed and stored at  20 C.
The oligonucleotide sequences are as follows:
Pr2HNF-1(Self) 50-TGGTCCACCAGGTGGTTAATATT-
TGACCCAG-30
Pr2mHNF-1(mSelf) 50-TGGTCCACCAGGTGATGAAG-
ATTTGACCCAG-30
The underlined residues are those mutated in the pGL3
Pr2mHNF-1 promoter construct.
EMSA
About 6 mg of the rat liver nuclear extract (3 mg/ml, Active
Motif) was pre-incubated at 4 C for 20 min in the presence or
absence of 2 ml antibody. Competing unlabeled oligonuc-
leotide (100-fold molar excess, Self or mSelf) was added
prior to the addition of 2 ml of the biotin-labeled probe.
After a 20 min incubation at 4 C, 1 ml of high-density sample
buffer (Novex, San Diego, CA) was added and the samples
were evaluated by electrophoresis in a 6% polyacrylamide
DNA retardation gel (Invitrogen, San Diego, CA) with
0.25· TBE running buffer at a constant 100 V at 4 C for
1.5 h. The gel was transferred to a positively charged nylon
membrane (Pierce, Rockford, IL) in 0.5· TBE at a constant
30 V at 4 C for 1 h. The DNA was ﬁxed to the membrane by
UV cross-linking (UV Stratalinker 1800, Stratagene). The
membrane was developed using the Chemiluminescent
Nucleic Acid Detection Module (Pierce). Brieﬂy, the mem-
brane was blocked for15 minatroom temperaturefollowed by
a 15 min incubation in streptavidin-horseradish peroxidase
conjugate. The membrane was then washed extensively fol-
lowed by a 5 min incubation in substrate equilibration buffer.
Finally, the membrane was developed in a 1:1 mixture of
luminol enhancer solution and peroxide for 5 min. The mem-
brane was exposed to X-ray ﬁlm for 15–60 s and developed.
The following rabbit polyclonal antibodies were used:
anti-HNF-1a either from Active Motif (Nushift HNF1a kit)
and/or from Santa Cruz (sc10791X, 2 mg/ml); anti-HNF-
1b (sc-22840X, 2 mg/ml, Santa Cruz) and anti-GATA4
(sc-1237X, 2 mg/ml, Santa Cruz).
Northern and Southern analysis
Multiple-tissue and cell line Northern membranes from
Clontech (Palo Alto, CA) were prehybridized and hybridized
following the manufacturer’s instructions. The hybridization
was performed with either a radiolabeled or a biotin labeled
(BrightStar Psoralen-biotin, Ambion) open reading frame
probe of mouse RNase 4 (GenBank accession no.
AY762362, nt 93–537). The membranes were washed and
exposed to the ﬁlm overnight. The actin gene was used as a
control for RNA loading and integrity. For the Southern blot,
10 mg of 129SV mouse genomic DNA provided by Jiliang Gao
(National Institutes of Health, Bethesda, MD) was digested
with the indicated restriction enzymes overnight at 37 C. The
digested DNA was electrophoresed on a 0.8% agarose gel and
then transferred to a positively charged membrane. Following
prehybridization, the blot was hybridized with the biotin
labeled probe.
Generation of the mouse RNase 4 expression construct
and production of recombinant protein
The portion of the open reading frame encoding the predicted
mature RNase 4 peptide (GenBank accession no. AY762362,
nt 178–534) was ampliﬁed from liver cDNA using the follow-
ing primers:
Forward: 50-ctcctcctcAAGCTTCTCAGGATCGAATGTA-
CCAAC-30
Reverse: 50-ctcctcctcGAATTCTCTGTCAAAGTGCACT-
GGGAC-30
(underlined residues encode engineered restriction enzyme
sites). The PCR product was subcloned into pCR2.1 for
sequencing and then the RNase 4 insert was excised using
HindIII and EcoRI and then ligated in frame into the prepared
pFlag CTS bacterial expression vector (International Biotech-
nologies, Inc., New Haven, CT). The ﬁdelity of the expression
construct was conﬁrmed by sequencing. Production and
isolation of recombinant mouse RNase 4 from bacterial
transfectants was performed as described previously (22).
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the comparison with serial dilutions of known concentrations
of a FLAG-conjugated protein standard on western blots. The
western blot was incubated with monoclonal anti-FLAG anti-
body (Sigma) followed by HRP conjugated sheep anti-mouse
IgG and developed with reagents from Amersham.
Determination of ribonuclease activity against
tRNA substrate
The assay used was adapted from the procedure of Slifman
et al. (23) as described previously (22). Calculations included
the following approximations: the average molecular weight
(Mr) of tRNA as 28100 (75–90 ribonucleotides/tRNA
molecules · Mr 341/ribonucleotide), with A260 of 1.0 corres-
ponding to 40 mg/ml RNA. All time points represent averages
of the triplicate samples.
Evolutionary analysis of DNA sequences
RNase 4 mature protein sequence from Mus musculus—house
mouse, Q9JJH1; Rattus norvegicus—Norway rat, O55004;
Homo sapiens—human, P34096; Pan troglodytes—
chimpanzee, Q8HZQ0; Bos taurus—cow, P15467 and Sus
scrofa—pig, P15468 were aligned using ClustalW. A
neighbor-joining phylogenetic tree was reconstructed with
p-distances and bootstrap percentages derived from 2000 rep-
lications were used to evaluate the reliability of the tree (24).
RESULTS
Identification and chromosomal localization of
the mouse RNase 4 gene
A genomic sequence encoding mouse (M.musculus) RNase 4
was identiﬁed by homology to the human RNase 4 coding
region (D37931) in the Celera Mouse Genome Database.
This sequence was used to identify the mouse and rat
sequences in the public domain genome sequences and for
oligonucleotide design in order to amplify mouse full-
length cDNA from reverse transcribed liver RNA. Addition-
ally, RNase 4 from R.norvegicus (Norway rat), H.sapiens
(human), P.troglodytes (chimpanzee), B.taurus (cow) and
S.scrofa (pig) were collected from the GenBank on the
basis of their homology to the mouse RNase 4 utilizing the
BLAST algorithm.
Northern analysis and RACE
Transcripts encoding mouse RNase 4 ( 1.4 kb) were detected
in the prostate, thyroid, salivary glands, uterus, heart, lung,
liver, and kidney of mice (Figure 1A). No hybridization sig-
nals were detected in the large intestine, stomach, thymus,
brain, spleen, skeletal muscle or testis. Mouse RNase 4 has
a pattern of tissue expression similar to that of human RNase 4,
which was readily detected by northern analysis in heart, lung
liver, skeletal muscle, kidney and pancreas (17). Transcripts
encoding mouse RNase 4 were also detected in several cell
lines with highest levels of expression in the RAW 264.7
mouse macrophage and the Hepa 1-6 hepatoma cell lines
(Figure 1B). Since liver expressed such abundant amounts
of RNase 4 message, liver RNA was used to determine the
full transcript size. In addition to the experimentally derived
Figure 1. (A) Northern analysis of RNase 4 expression in mouse tissues. A
460ntprobeinclusiveoftheopenreadingframeofmouseRNase4wasusedto
hybridize mouse multi-tissue northern blots. (B) Northern analysis of RNase 4
expression in mouse cell lines. A 460-nucleotide probe inclusive of the open
reading frame of mouse RNase 4 was used to hybridize a mouse cell line
northern blot. Lane 1, lymphoid; lane 2, leukemia; lanes 3 and 4, fibroblast;
lane 5, connective; lane 6, carcinoma; lane 7, hepatoma; lanes 8 and 10, lym-
phoma; lane 9, lymphocytic leukemia; lane 11, mast cell; lane 12, neuroblas-
toma. (C) Neighbor-joining phylogenetic tree of RNase A superfamily
members. Swiss protein database accession numbers for amino acid sequences
are as follows: mouse RNase 4 (boxed), Q9JJH1 (box); rat RNase 4, O55004
(29–147); human RNase 4, P34096 (29–147); chimpanzee RNase 4, Q8HZQ0
(29–147); cow RNase 4, P15467 (1–119); pig RNase 4, P15468 (29–147);
mRNase 5/Ang 1, P21570 (25–145); mAng2/Angrp, Q64438 (25–145);
mAng4, Q9JJH1 (30–148); mAng3/Anglp, P97802 (24–144); mRNase 1,
P00683 (26–149); mEar11, (predicted from AF512015); mEar2, P97425
(28–156); and mEar1, P97426 (28–155); mRNase 6, AY545655; mRNase 9,
AY226989; mRNase 10, AY226990. Only three of the 10–15 mEar genes are
shown due to space constraints. Unrooted phylogenetic tree and bootstrap
percentages (2000 replications, at branch points) were obtained using
MEGA2 (24).
1080 Nucleic Acids Research, 2005, Vol. 33, No. 3Figure 2. (A) An alignment of RNase 4 amino acid sequences. Amino acids 1–28 are components of the signal sequence and amino acids 29–147 form the mature
protein. Residues 40, 68 and 144 form the catalytic triad and the eight cysteines (amino acids 53, 67, 85, 92, 99, 109, 120 and 135) form the disulfide bonds. The
residues in bold are those shown to be conserved in all RNase A family members. The aspartic acid (D) at position 108 (arrow) has been shown to be involved in
substratespecificity(41).Consensuslinehighlightsidentical(*)andconserved(.or:)aminoacids.(B)WesternanalysisofrecombinantmouseRNase4protein.The
arrow highlights bacterial alkaline phosphatase (BAP) used as a positive control and the arrow heads indicates mouse RNase 4 with the lower, darker band
corresponding to the fully processed, active enzyme. (C) Enzymatic activity of recombinant mouse RNase 4 against yeast tRNA substrate. Double reciprocal plot
used to generate enzymatic constants for mouse RNase 4.
Nucleic Acids Research, 2005, Vol. 33, No. 3 1081cDNAs, several liver ESTs were found by homology search
(AI787202, AI96225, AI530414, AI663624 and AW412859).
The total size of the liver RNase 4 transcript is 1409 nt, which
is in agreement with the northern analysis.
Southern analysis reveals that mouse RNase 4 is a single
copy gene (data not shown). RNase 4 is localized to mouse
chromosome 14 between RNase 5/ang 1 and RNase 6 (25,26)
in both the mouse and human genome and on chromosome 15
(NW_047453, Build 2) in rat indicating a syntenic relationship
as would be expected of orthologous genes. Phylogenetic ana-
lysis demonstrates that mouse RNase 4 is more closely related
to RNase 4 of non-mouse species than it is to other mouse
RNase A gene lineages (Figure 1C). Sequence analysis reveals
that the RNase 4 predicted protein sequences are 83–99%
identical to each other over the length of the mature protein.
Takentogether,these data suggest strongorthologousrelation-
ships among these ribonuclease sequences.
Ribonuclease activity of mouse RNase 4
The RNases 4 from each species contain the eight cysteines
necessary for folding, the histidines (amino acid position 40
and 144) and the lysine (position 68) that form the catalytic
site, as well as the CKXXNTF motif found in all members of
the RNase A superfamily (Figure 2A). Recombinant mouse
RNase 4 was isolated from the periplasm of bacteria using the
pFLAG CTS expression system (Figure 2B) and 2.4 pmol
recombinant protein was used to generate a double reciprocal
Figure 3. (A) Gene structure of the mouse RNase 4 and RNase 5/ang 1 locus. Exons are represented as boxes and introns are the intervening lines. The numbering
denotesthesizeofeachsegmentinthemousegenome.TheRNase5/ang1codingsequenceisonexonIIIandtheRNase4codingsequenceisonexonIV.Lowercase
lettersandarrowsindicatelocationanddirectionofRT–PCRprimersusedtogeneratedatafeaturedin (B).Pr1andPr2refertopromotersexaminedinFigure5.(B)
Tissue-specific detection of exon I/exon II variants. RT–PCR was performed using primers complementary to sequences in either exon I (primer a, upper panel of
eachpair)orexonII(primerb,lowerpanelofeachpair)inconjunctionwithprimerscomplementarytothesequenceofthecodingregionofRNase5/ang1(primerc,
exonIII)orRNase4(primerd,exonIV)toidentifytissue-specificexpressionofindividualvariants.Splicingpatternandrelativepositionofprimersareshowninthe
left hand side of Figure while RT–PCR data is shown in the right. Actin primers were used as a positive control.
1082 Nucleic Acids Research, 2005, Vol. 33, No. 3plot (Figure 2C). The catalytic constants determined using the
yeast tRNA substrate are kcat = 0.17 s
 1, Km = 0.43 mM and the
catalytic efﬁciency of kcat/Km = 3.8 · 10
5 M
 1s
 1, which are
similar to those of human and pig RNase 4 against the UpA
substrate [kcat/Km = 2.46 · 105 M
 1s
 1 (15) and 2.5 ·
10
5 M
 1s
 1 (27), respectively]. The catalytic efﬁciency of
mouse RNase 4 against yeast tRNA is within the range of
other RNase A enzymes against this substrate [human
RNase 2, kcat/Km = 1.3 · 10
6 M
 1s
 1 (17); mEar 6, kcat/
Km = 8.7 · 10
5 M
 1s
 1 (28); mRNase 6, kcat/Km = 4 ·
105 M
 1s
 1 (25)] and establishes mouse RNase 4 as an
active enzyme.
Differential splicing and exon sharing between
RNase 4 and RNase 5/ang 1
We determined the gene structure of mouse RNase 4
(Figure 3A) by mapping our experimentally-determined
RACE products from the liver and kidney as well as EST
sequences onto the mouse genomic sequence. Furthermore,
RNA from various tissues was screened by RT–PCR for the
presence of the non-coding exons together with the coding
exons of RNase 5/ang 1 and RNase 4. As can be seen in
Figure 3B, the transcript containing exon II is found primarily
in the liver (lane 5) while exon 1 can be detected in all tissues.
This differential non-coding exon usage is observed for both
mouse RNase 4 and RNase 5/ang 1. Note that in the kidney
(lane 7), RNase 4 is seen in conjunction with both exon I and
exon II. The four exon gene structure and 50-UTR sharing
between RNase 4 and RNase 5/ang 1 were determined to
be a feature of the mouse, human and rat genome by analysis
of the 50 RACE products from at least two RNA sources from
each species followed by mapping of the RACE products and
database ESTs onto the appropriate genome. ESTs were
identiﬁed by BLAST analysis of the protein coding region
against mouse, human and rat EST databases. EST fragments
extending the sequence in the 50 direction were used in this
analysis to conﬁrm experimental RACE data shown in
Figure 4. In the human, mouse and rat transcriptomes, exon
I (Figure 4B) is seen in transcripts from liver, kidney and
placenta while exon II (Figure 4C) has a more restricted
expression being detected primarily in the liver and occasion-
ally in the kidney.
Tissue-specific promoters
One way to regulate the expression of RNase 4 and invoke
differential expression of exons I and II would be by the use of
two different promoters. We characterized the promoter activ-
ity of 500 nt 50 to exon I (Promoter 1, Pr1, NT_039599, nt
6429595–6430094) and 500 nt 50 to exon II (Promoter 2, Pr2,
NT_039599, nt 6434259–6434758) in several cell lines
(Figure 5A). The activity from the Promoter 1-containing
construct was detected at 4- to 8-fold over background levels
and was moreor less equivalent in all cell lines examined. This
is consistent with the expression of exon I-containing
transcripts in multiple tissues. Interestingly, the Promoter
2-containing construct has minimal transcriptional activity
in all but the Hepa 1-6 liver cell line (2-fold over background
compared with 9-fold in the Hepa 1-6 cells). Promoter 2 con-
tains a sequence similar to the consensus binding site for the
hepatocyte nuclear factor (HNF)-1 family of transcription fac-
tors (29). When mutations are introduced into the putative
HNF-1 site, the mutated promoter construct (Pr2mHNF-1)
Figure 4. (A)Schematicofmouse,ratandhumanRNase4andRNase5locus.Supportfortheexistenceofeachtranscriptwasgeneratedby50 RACEfromthetissue
indicated and by the detection of ESTs in the mouse, human and other EST databases. Pr1 and Pr2 refer to the promoters examined in Figure 5. (B) RNase 4—exon
I-containing transcripts found in most tissues (C) RNase 4—exon II-containing transcripts found primarily in the liver.
Nucleic Acids Research, 2005, Vol. 33, No. 3 1083Figure 5. (A)DifferentialactivityofPromoter1(Pr1,500nt50 ofexonI)andPromoter2(Pr1,500nt50 ofexonII)invariousmousecelllines.Eachexperimentwas
performedintriplicate;thenumberofexperimentsperformedisindicated(n).ValuesarenormalizedtopGL3Basicwhichlacksapromoteranddataarereportedas
mean – SEM;*P < 0.01betweenPr2 andPr1. Transcriptionfrom Pr2in responseto mutagenesisof theputativeHNF-1sitein the(B) mouseHepa1-6 cellline; (C)
human HepG2 cell line; (D) rat H4IIE cell line. *P < 0.001 between Pr2 and Pr2mHNF-1, n = 3. (E) EMSA analysis. Biotin-labeled probe corresponding to nt
6434577–6434607ofGenBankaccessionno.NT_039599inthemouseliverPr2sequencewasincubatedwithratliverextractintheabsence(lane2)orpresenceof
excessunlabeledprobe(lane3)orprobeinwhichtheHNF-1sitehadbeenmutated(lane4).Pre-incubationwithtwodifferentanti-HNF1aantibodies(lanes5and6);
isotype control (HNF1b-lane 7). The open arrowheads denote non-specific DNA–protein interactions; the arrow (left) denotes specific DNA–protein interaction
while the filled arrow head on right highlights the DNA–protein–antibody complex or ‘supershift’.
1084 Nucleic Acids Research, 2005, Vol. 33, No. 3lostsigniﬁcanttranscriptionalactivityinmouse,ratandhuman
hepatic cell lines (Figure 5B–D, respectively). EMSA analysis
revealed speciﬁc binding of the transcription factor HNF-1a to
this site in rat liver nuclear extract (Figure 5E). The supershift
seen with two distinct anti-HNF-1a antibodies (lanes 5 and 6)
was not replicated with an antibody directed towardthe related
HNF-1b protein which was used here as an isotype control
(lane 7).
DISCUSSION
In this work, we explore the RNase 4 and RNase 5/ang 1 gene
locus in three species and demonstrate an unusual gene struc-
ture consisting of four exons and three introns (Figure 3A).We
demonstrate that the shared 50-UTRs of RNase 4 and RNase 5/
ang 1 arise from differential splicing of two shared non-
coding exons conﬁrming the results of Strydom (5). We also
demonstrate the potential for tissue-speciﬁc expression regu-
lated by dual promoters and the presence of tissue-speciﬁc
expression mediated by at least one unique consensus binding
site in the proximal 50 promoter. Transcription from multiple
promoters is not uncommon in the mammalian genome and
provides a means for differential production of gene tran-
scripts in response to speciﬁc environmental cues. Among
some examples, Li et al. (30) described the dual promoters
regulating the expression of eosinophil granule major basic
protein (MBP) during different stages of eosinophil develop-
ment. Similarly, CD94, a C-type lectin expressed on NK cells
and T-cell subsets, is controlled by dual promoters that differ
in their responsiveness to cytokines IL-2 and IL-15 (31) and
determine expression in T-cell subsets (32). Interestingly, we
have known for quite some time that at least one of the RNase
A ribonucleases, RNase 3/eosinophil cationic protein, is
expressed uniquely in eosinophils (33) and yet the mechanism
underlying this tissue-speciﬁc expression has been elusive.
Not only is this work the ﬁrst demonstration of dual promoters
among the RNase A ribonucleases, it is likewise the ﬁrst
demonstration of a mechanism underlying tissue-speciﬁc
expression.
Taken together, our promoter analysis and the RACE/EST
data indicate that the distal promoter, Pr1, directs the tran-
scription of RNase 4 and angiogenin utilizing the ﬁrst non-
coding exon (Figure 3B). In this situation, when transcripts for
RNase 4 are produced, exon II and exon III (encoding RNase
5/ang 1) will be spliced out or not recognized as exons. The
proximal promoter, Pr2 directs liver-speciﬁc expression
resulting in the splicing of the second of the two non-
coding exons with the appropriate coding exon. Again,
when RNase 4 transcripts are produced, exon III encoding
RNase 5/ang 1 is spliced out or not recognized as an exon.
Pr2 contains a consensus binding site for the transcription
factor, HNF-1a, and we demonstrate that point mutations in
the consensus sequence reduce promoter activity to baseline
levels in luciferase assays performed in vitro in relevant liver
cell lines. HNF-1a is a dimerizing homeodomain protein that,
together with other transcription factors, coordinates the
expression of transcripts encoding hepatocyte proteins
(29,34). Originally perceived to be hepatocyte-speciﬁc,
HNF-1a expression itself is not limited to hepatocytes
(35,36). Moreover, speciﬁc mutations in HNF-1a result in
the genetic syndrome known as maturity onset diabetes of
the young (MODY) (29,37), and the targeted HNF-1a
gene-deletion likewise has elucidated clear alterations in
gene-expression in mouse pancreatic tissue (38–40). The
RNase 4 and RNase 5/ang 1 proximal promoter Pr2 also
has consensus binding sites for the transcription factors
HNF-3 and the CCAAT-enhancer binding protein (C/EBP)
family which may coordinate with HNF-1a in promoting
gene expression. Clearly, the predominant expression of
RNase 4 and RNase 5/ang 1 in the liver tissue may be due
to the action of Pr2 in vivo in humans, mice and rats as sug-
gested by the RACE, EST and promoter data shown here.
While other members of the RNase A superfamily have
intriguing evolutionary patterns, unusual expression patterns
and/or unique protein structure and function, there has been
only limited interest in the highly conserved RNase 4 lineage.
However, in this work, we demonstrate the rather unusual
nature of its regulatory mechanism and demonstrate the ﬁrst
molecular mechanism underlying tissue-speciﬁc expression in
this gene family. These ﬁndings certainly provide greater
impetus to study RNase 4 and its speciﬁc function vis a ` vis
hepatocytes and liver metabolism. Furthermore, given that
RNase 4 and RNase 5/ang 1 are transcribed from the same
promoters and can be expressed in concert, equally
intriguing is the possibility of coordinate activity of the two
gene products (5).
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